diane feinstein

warning: Creating default object from empty value in /home/hemporg/public_html/news/modules/taxonomy/taxonomy.pages.inc on line 34.

U.S.: Senate Members To Investigate Barriers To Researching Marijuana Extract CBD

USSenateFlag

The U.S. Senate Caucus on International Narcotics Control will hold a hearing Wednesday morning on cannabidiol (CBD), a component of marijuana being used in the treatment of seizure disorders and other medical conditions, and federal obstacles to studying its efficacy.

The hearing, “Cannabidiol: Barriers to Research and Potential Medical Benefits” will be led by Sens. Charles Grassley (R-IA) and Diane Feinstein (D-CA), who have long been opponents of efforts to reform federal marijuana laws.

Sens. Cory Booker (D-NJ) and Kirsten Gillibrand (D-NY) have been invited to participate. They are sponsors of the CARERS Act, bipartisan legislation that would resolve the tension between state and federal marijuana laws.

The hearing is expected to focus on the use of CBD in the treatment of seizure disorders rather than whole-plant medical marijuana and the many other medical conditions for which doctors frequently recommend it. It is also expected to focus on federally regulated distribution channels rather than state-regulated medical marijuana providers.

WHAT: Hearing on CBD research and efficacy

WHEN: Wednesday, June 24, 9:30 a.m. ET

WHERE: Dirksen Senate Office Building, Room 226, Washington, D.C.

WHO: Dr. John Brad Ingram, child neurologist, University of Mississippi
Dr. Tom Minahan, emergency physician and parent of child with seizure disorder
Joseph Rannazzisi, deputy assistant administrator, Office of Diversion Control, Drug Enforcement Administration (DEA)
Dr. Kevin Sabet, anti-marijuana activist, Project SAM

U.S.: Drug Policy Alliance Mocks Scandal-Ridden DEA With "Help Wanted" Ad

DrugPolicyAllianceDEAHelpWantedAd

Ad is Part of Campaign to Influence Obama’s Next DEA Pick, End Agency’s Opposition to Marijuana Law Reform, and Ultimately Reform or Abolish the Agency

As States Legalize Marijuana and Tide Turns Against the Failed Drug War, DEA Increasingly Scrutinized

The Drug Policy Alliance has placed a mock “Help Wanted” ad in Roll Call seeking a new head of the Drug Enforcement Administration (DEA) to “prolong the failed war on drugs.” Primary areas of job responsibility include “Mass Incarceration,” “Police State Tactics,” “Obstruction of Science,” “Subverting Democracy” and “Undermining Human Rights.”

The ad comes in the wake of numerous DEA scandals and DEA Administrator Michele Leonhart’s recent announcement she will resign sometime in May.

“Drug prohibition, like alcohol Prohibition, breeds crime, corruption, and violence – and creates a situation where law enforcement officers must risk their lives in a fight that can’t be won,” said Ethan Nadelmann, executive director of the Drug Policy Alliance (DPA). “It’s time to reform not just the DEA but broader U.S. and global drug policy.

"The optimal drug policy would reduce the role of criminalization and the criminal justice system in drug control to the greatest extent possible, while protecting public safety and health,” Nadelmann said.

Syndicate content